Skip to main content
. 2022 May 13;15:100289. doi: 10.1016/j.mtbio.2022.100289

Fig. 2.

Fig. 2

The anti-breast cancer effect of IC/IR820 NPs. (A–C) Viability of MDA-MB-231, MCF-7, and 4T1 cells co-cultured with IC, IR820, and IC/IR820 nanoparticles. (λ ​= ​808 ​nm, P ​= ​1.0 ​W/cm2; irradiation time ​= ​20 ​s). (D–G) Representative images for colony formation of MDA-MB-231, MCF-7, and 4T1 cells co-cultured with IC, IR820, and IC/IR820 nanoparticles. ∗∗∗P ​< ​0.001. (λ ​= ​808 ​nm, P ​= ​1.0 ​W/cm2; irradiation time ​= ​30 ​s). (H–K) Quantification of MDA-MB-231, MCF-7, and 4T1 cells co-cultured with IC, IR820, and IC/IR820 nanoparticles in the EDU assay. Scale bar: 20 ​μm. (λ ​= ​808 ​nm, P ​= ​1.0 ​W/cm2; irradiation time ​= ​20 ​s). (L–N) LDH assay of MDA-MB-231, MCF-7, and 4T1 cells co-cultured with IC, IR820, and IC/IR820 nanoparticles. (λ ​= ​808 ​nm, P ​= ​1.0 ​W/cm2; irradiation time ​= ​20 ​s).